# Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

> **NCT02490098** · PHASE2 · WITHDRAWN · sponsor: **Institut de Recherches Cliniques de Montreal**

## Conditions studied

- Type 1 Diabetes

## Interventions

- **OTHER:** 6-day intervention with sensor-augmented pump therapy
- **OTHER:** 6-day intervention with single-hormone closed-loop strategy
- **OTHER:** 6-day intervention with dual-hormone closed-loop strategy
- **DRUG:** Insulin
- **DRUG:** Glucagon
- **DEVICE:** Continuous Glucose Monitoring System Enlite sensor®, Medtronic
- **DEVICE:** Insulin pump MiniMed® Paradigm® Veo™, Medtronic

## Key facts

- **NCT ID:** NCT02490098
- **Lead sponsor:** Institut de Recherches Cliniques de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-01
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding terminated
- **Last updated:** 2017-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02490098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02490098, "Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02490098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*